Showing 13,561 - 13,580 results of 105,129 for search '(( i wt decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.67s Refine Results
  1. 13561
  2. 13562
  3. 13563
  4. 13564
  5. 13565
  6. 13566

    <i>Ex vivo</i> deletion of <i>sirt1</i> decreases expression of RUNX2 downstream targets. by Kayvan Zainabadi (502381)

    Published 2017
    “…The homeodomain transcriptional regulators, Msx2, Dlx3, and Dlx5, help establish the early osteoblast transcriptional program, including upregulation of Runx2 expression and activity [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0178520#pone.0178520.ref017" target="_blank">17</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0178520#pone.0178520.ref021" target="_blank">21</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0178520#pone.0178520.ref024" target="_blank">24</a>]. …”
  7. 13567
  8. 13568
  9. 13569

    Supplementary Material for: Structural and functional effects of C5aR1 antagonism in a rat model of neonatal hypoxic-ischemic encephalopathy by Saadat A. (18613231)

    Published 2024
    “…Reasoning C5aR1 antagonism can decrease excessive neuroinflammation and thereby improve neurological and functional outcomes, we tested this hypothesis in a rat model of HIE with PMX205, a small molecule that inhibits C5a-C5aR1 interaction. …”
  10. 13570

    Female EIIIA-cFN null mice have decreased accumulation of intracellular lipids at day 2 after PHx. by Bridget Sackey-Aboagye (3221319)

    Published 2016
    “…Oil Red O staining was decreased in female EIIIA-cFN null mice <b>(B)</b> in comparison to wild type littermates <b>(A)</b>. …”
  11. 13571

    1,8-cineol-treamtent leads to significantly decreased levels of MUC gene expression after their LPS-dependent stimulation. by Holger Sudhoff (109301)

    Published 2015
    “…<p><b>A</b>: Real time PCR analyses of nasal slice culture depicted increased levels of MUC2 after LPS-treatment, which were significantly reduced in LPS- and 1,8-cineol-treated approaches. …”
  12. 13572
  13. 13573
  14. 13574
  15. 13575
  16. 13576
  17. 13577

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice. by Pia Steensland (362091)

    Published 2013
    “…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). However, ezlopitant treatment failed to induce a significant decrease in ethanol consumption compared to vehicle (<b>B</b>). …”
  18. 13578
  19. 13579
  20. 13580